Reuters exclusively reports EU regulator to decide on Pfizer booster dose at the start of October


Reuters exclusively reported that the European Medicines Agency expects to decide in early October on the possible use of a booster dose of the Pfizer-BioNTech, COVID-19 vaccine. It will be the EU drugs regulator’s first decision on boosters, after the U.S. Food and Drug Administration authorized a third dose of Pfizer for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Europe

Countries: Belgium

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *